Document is current
Any future updates will be listed below
-
Authors
Twelves, Chris
Cheeseman, Sue
Sopwith, Will
Thompson, Matthew
Riaz, Majid
Ahat-Donker, Necibe
Myland, Melissa
Lee, Adam
Przybysz, Raymond
Turner, Stuart
Hall, Geoff
Perren, Tim
-
Funding
Funding for this research was provided by:
Novartis Pharmaceuticals Corporation
- License Information
-
More Information
Article History
Received: 1 August 2019
Accepted: 9 January 2020
First Online: 21 January 2020
Ethics approval and consent to participate
: The study was completed with UK Health Research Authority formal approval; the need for ethics approval was waived.
: No consent required.
: REAL Oncology is a collaboration between Leeds Cancer Centre, the University of Leeds and IQVIA™. Commercial clients of IQVIA include Novartis Pharmaceuticals, which funded the work this paper is based on. REAL Oncology retains all operational, scientific and communications controls. CT, SC, GH and TP are employees of LCC. WS, MT, MR, NA-D and MM are employees of IQVIA. AL, RP and ST are employees of Novartis. There are no further conflicts of interest.
